CA
NZ
UK
AU
IND
US
Director Nancy Harris filed a Form 144 notice of proposed sale with the SEC on November 9, 2026, disclosing plans to sell 3,256 shares of Intapp Inc. common stock on NASDAQ.
Director Roger Anthony Carolin filed a Form 4 with the SEC on November 9, 2026, disclosing the exercise of a stock option covering 20,000 shares of Amkor Technology, Inc. common stock on November 5, 2026.
Kevin K. Engel, an officer and director of Amkor Technology, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 1,000 shares of Amkor common stock pursuant to Rule 144 under the Securities Act of 1933.
Teradata Corporation director and officer Stephen McMillan filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 10,000 shares of Teradata common stock on the New York Stock Exchange.
Director Edward D. Breen filed a Form 4 with the SEC on November 9, 2026, disclosing a same-day exercise and sale of 89,845 stock options in DuPont de Nemours, Inc. (NYSE:DD) on November 5, 2026, along with a prior grantor retained annuity trust transaction …
DuPont de Nemours, Inc. CEO and Director Lori Koch filed a Form 4 on November 9, 2026, disclosing the exercise of 2,311 stock options and the same-day sale of 2,311 shares of common stock.
Erik T. Hoover, SVP and General Counsel of DuPont de Nemours, Inc., filed a Form 4 on November 9, 2026, disclosing the exercise of stock options and the same-day sale of 4,203 shares of common stock.
DuPont de Nemours, Inc. officer Erik T. Hoover filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 4,203 shares of common stock acquired through the exercise of employee stock options.
Amylyx Pharmaceuticals, Inc. director and officer Justin Klee filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 100,000 shares of common stock through Morgan Stanley Smith Barney LLC.
DuPont de Nemours, Inc. officer Lori Koch filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 2,311 shares of common stock to be acquired through a broker-assisted cashless exercise of employee stock options on the same date.
Please wait processing your request...